Generics in the United States : Market Research Report

Generics in the United States

Published by: Datamonitor

Published: Sep. 4, 2008 - 30 Pages

EXECUTIVE SUMMARY
CHAPTER 1 Market Overview: 1.1 Market Definition; 1.2 Research Highlights; 1.3 Market Analysis
CHAPTER 2 Market Value
CHAPTER 3 Market Segmentation I
CHAPTER 4 Market Segmentation II
CHAPTER 5 Five Forces Analysis: 5.1 Summary; 5.2 Buyer Power; 5.3 Supplier Power; 5.4 New Entrants; 5.5 Substitutes; 5.6 Rivalry
CHAPTER 6 Leading Companies: 6.1 Teva Pharmaceutical Industries; 6.2 Mylan Laboratories Inc; 6.3 Watson Pharmaceuticals, Inc.
CHAPTER 7 Market Forecasts: 7.1 Market Value Forecast
CHAPTER 8 Appendix: 8.1 Methodology; 8.2 Industry Associations; 8.3 Related Datamonitor Research
LIST OF TABLES: Table 1: United States Generics Market Value: $ billion, 2003-2007; Table 2: United States Generics Market Segmentation I: % Share, by Value, 2007; Table 3: United States Generics Market Segmentation II: % Share, by Value, 2007; Table 4: Key Facts: Teva Pharmaceutical Industries; Table 5: Key Financials: Teva Pharmaceutical Industries; Table 6: Key Facts: Mylan Laboratories Inc.; Table 7: Key Financials: Mylan Laboratories Inc.; Table 8: Key Facts: Watson Pharmaceuticals; Table 9: Key Financials: Watson Pharmaceuticals; Table 10: United States Generics Market Value Forecast: $ billion, 2007-2012

Abstract

Datamonitor's Generics in the United States industry profile is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

Contains an executive summary and data on value, volume and/or segmentation
Provides textual analysis of the industry’s recent performance and future prospects
Incorporates in-depth five forces competitive environment analysis and scorecards
Includes a five-year forecast of the industry
The leading companies are profiled with supporting key financial metrics
Supported by the key macroeconomic and demographic data affecting the market

Highlights

Detailed information is included on market size, measured by value and/or volume
Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

Why you should buy this report

Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research

Market Definition

The value of the generics market consists of all sales of generics drugs at ex-manufacturers prices. The market does not include animal healthcare products. Datamonitor defines a generic as a product, which is an officially approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name. This definition excludes multi-source copy products that make up much of markets such as India, Spain and Italy. All currency conversions have been calculated at constant 2007 average exchange rates.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Generics in the United States

Table of Contents

Abstract